This site is intended for healthcare professionals
Further information
MHRA Drug Safety Update
The use of aceclofenac is now contraindicated in patients with certain established cardiovascular diseases, including ischaemic heart disease, peripheral arterial disease, cerebrovascular disease and congestive heart failure. Treatment with the drug should be initiated only after careful consideration of any significant cardiovascular risk factors.
Recent cardiovascular safety concerns have led the...
The most up-to-date drug information at your fingertips.
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
NICE has withdrawn its recommendation to quadruple...
Use our timeline to follow the latest coronavirus developments...
NICE has issued guidance on antibiotic choices and...
The MHRA has amended its advice relating to the long-acting...
Drugs
Conditions
News and resources
MIMS Hosted